Allworth Financial LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Allworth Financial LP

  • $15.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022
BUY
$83.14 - $145.99 $1,579 - $2,773
19 Added 19.79%
115 $17,000
Q1 2022

Apr 22, 2022
BUY
$110.08 - $142.92 $10,567 - $13,720
96 New
96 $11,000
Q4 2021

Jan 21, 2022
SELL
$99.73 - $148.48 $7,878 - $11,729
-79 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$98.85 - $138.91 $7,809 - $10,973
79 New
79 $11,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email